View More View Less
  • 1 Kanizsai Dorottya Kórház, Nagykanizsa, Erkel Ferenc utca 1/1/3., 8800
  • 2 Kanizsai Dorottya Kórház, Nagykanizsa
  • 3 Pannon Egyetem, Nagykanizsai Kampusz, Nagykanizsa
  • 4 Pécsi Tudományegyetem, Általános Orvostudományi Kar, Pécs
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

Absztrakt

Bevezetés: A cryosclerosist Milleret és Le Pivert mutatta be az 1980-as években. Módszer: A szerzők egy prospektív nem randomizált összehasonlító vizsgálatot végeztek 96 betegen. 48 esetben cryosclerosis, a többinél stripping történt. Középtávon 52 esetet sikerült értékelni. A vizsgálat elsődleges végpontjaként a cryosclerosis occlusiós arányát vizsgálták. Másodsorban a klinikai sikertelenséget, a Klinikai Etiológiai Anatómiai Patofiziológiai klasszifikációban és a Vénás Klinikai Súlyossági Pontokban bekövetkezett változásokat elemezték. Eredmények: Egy esetben (4%) észlelték a kezelt vena saphena magna teljes rekanalizációját, amely klinikai sikertelenséggel párosult. Négy vena saphena magna (15%) kinyílt, de ezek nem okoztak főtörzsi elégtelenséget. Az occlusiós arány 81%-os volt középtávon. Recidív varicositast a betegek 35%-ánál (cryosclerosis) és 42%-ánál (stripping) észleltek, nem volt szignifikáns különbség a csoportok között (log rank teszt, p = 0,391). A Klinikai Etiológiai Anatómiai Patofiziológiai klasszifikációban és a Vénás Klinikai Súlyossági Pontokban jelentős volt a javulás mindkét csoportban, azonban nem volt szignifikáns a különbség a csoportok között sem kiinduláskor, sem középtávon. Következtetések: A cryosclerosis – úgy tűnik – effektív a vena saphena magna remodellációjában. A módszernek nincsenek jelentős középtávú előnyei a klasszikus strippinggel szemben. Orv. Hetil., 2016, 157(50), 1994–2001.

  • 1

    Robertson, L. A., Evans, C. J., Lee, A. J., et al.: Incidence and risk factors for venous reflux in the general population: Edinburgh Vein Study. Eur. J. Vasc. Endovasc. Surg., 2014, 48(2), 208–214.

  • 2

    Lattimer, C. R.: CVD: a condition of underestimated severity. Int. Angiol., 2014, 33(3), 222–228.

  • 3

    Callam, M. J.: Epidemiology of varicose veins. Br. J. Surg., 1994, 81(2), 167–173.

  • 4

    Mariani, F., Mancini, S., Bucalossi, M., et al.: Selective high ligation of the sapheno-femoral junction decreases the neovascularization and the recurrent varicose veins in the operated groin. Int. Angiol., 2015, 34(3), 250–256.

  • 5

    Herman, J., Musil, D., Tichy, M., et al.: Recurrent varicose veins: causes and neovascularisation. A 17-year experience. Int. Angiol., 2015, 34(1), 53–59.

  • 6

    Carroll, C., Hummel, S., Leaviss, J., et al.: Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins. Br. J. Surg., 2014, 101(9), 1040–1052.

  • 7

    Nesbitt, C., Bedenis, R., Bhattacharya, V., et al.: Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database Syst. Rev., 2014, 30(7), CD005624.

  • 8

    Guex, J. J.: Endovenous chemical (and physical) treatments for varices: what’s new? Phlebology, 2014, 29(1 Suppl.), 45–48.

  • 9

    Nicolaides, A., Kakkos, S., Eklof, B., et al.: Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Int. Angiol., 2014, 33(2), 87–208.

  • 10

    Van den Bos, R. R., Proebstle, T. M.: The state of the art of endothermal ablation. Lasers Med. Sci., 2014, 29(2), 387–392.

  • 11

    Carradice, D.: Superficial venous insufficiency from the infernal to the endothermal. Ann. R. Coll. Surg. Engl., 2014, 96(1), 5–10.

  • 12

    Gloviczki, P., Comerota, A. J., Dalsing, M. C., et al.: The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J. Vasc. Surg., 2011, 53(5 Suppl.), 2S–48S.

  • 13

    Subwongcharoen, S., Chitwiset, S.: Chronic venous disease treated with endovenous microwave ablation: long-terms results and quality of life. J. Med. Assoc. Thai., 2014, 97(Suppl. 11), S76–S80.

  • 14

    Van den Bos, R. R., Malskat, W. S., De Maeseneer, M. G., et al.: Randomized clinical trial of endovenous laser ablation versus steam ablation (LAST trial) for great saphenous varicose veins. Br. J. Surg., 2014, 101(9), 1077–1783.

  • 15

    Elias, S., Lam, Y. L., Wittens, C. H.: Mechanochemical ablation: status and results. Phlebology, 2013, 28 (Suppl. 1) 10–14.

  • 16

    Balint, R., Vizsy, L., Farics, A., et al.: The role of cryosurgery in the treatment of the incompetent great saphenous vein. Int. Angiol., 2016, 35(1), 78–83.

  • 17

    Balint, I. B., Vizsy, L., Vargovics, E., et al.: Cryosclerosis. A forgotten endovenous procedure for treating the incompetence of the great saphenous vein. Short term results. Int. Angiol., 2014, 33(6), 547–552.

  • 18

    Garde, C.: Cryosurgery of varicose veins. J. Dermatol. Surg. Oncol., 1994, 20(1), 56–58.

  • 19

    Milleret, R., Le Pivert, P.: Cryosclerosis of the saphenous veins in varicose reflux in the obese and elderly. Phlebologie, 1981, 34(4), 601–605.

  • 20

    Disselhoff, B. C., der Kinderen, D. J., Kelder, J. C., et al.: Five-year results of a randomized clinical trial comparing endovenous laser ablation with cryostripping for great saphenous varicose veins. Br. J. Surg., 2011, 98(8), 1107–1111.

  • 21

    Disselhoff, B. C., Buskens, E., Kelder, J. C., et al.: Randomised comparison of costs and cost-effectiveness of cryostripping and endovenous laser ablation for varicose veins: 2-year results. Eur. J. Vasc. Endovasc. Surg., 2009, 37(3), 357–363.

  • 22

    Disselhoff, B. C., der Kinderen, D. J., Kelder, J. C., et al.: Randomized clinical trial comparing endovenous laser with cryostripping for great saphenous varicose veins. Br. J. Surg., 2008, 95(10), 1232–1238.

  • 23

    Klem, T. M., Schnater, J. M., Schütte, P. R., et al.: A randomized trial of cryo stripping versus conventional stripping of the great saphenous vein. J. Vasc. Surg., 2009, 49(2), 403–409.

  • 24

    Menyhei, G., Gyevnar, Z., Arató, E., et al.: Conventional stripping versus cryostripping: a prospective randomised trial to compare improvement in quality of life and complications. Eur. J. Vasc. Endovasc. Surg., 2008, 35(2), 218–223.

  • 25

    Cheatle, T. R., Kayombo, B., Perrin, M.: Cryostripping the long and short saphenous veins. Br. J. Surg., 1993, 80(10), 1283.

  • 26

    Rass, K., Frings, N., Glowacki, P., et al.: Same site recurrence is more frequent after endovenous laser ablation compared with high ligation and stripping of the great saphenous vein: 5 year results of a randomized clinical trial (RELACS Study). Eur. J. Vasc. Endovasc. Surg., 2015, 50(5), 648–656.

  • 27

    Gauw, S. A., Lawson, J. A., van Vlijmen-van Keulen, C. J., et al.: Five-year follow-up of a randomized, controlled trial comparing saphenofemoral ligation and stripping of the great saphenous vein with endovenous laser ablation (980 nm) using local tumescent anesthesia. J. Vasc. Surg., 2016, 63(2), 420–428.

  • 28

    Proebstle, T. M., Alm, B. J., Göckeritz, O., et al.: Five-year results from the prospective European multicentre cohort study on radiofrequency segmental thermal ablation for incompetent great saphenous veins. Br. J. Surg., 2015, 102(3), 212–218.

  • 29

    Doerler, M., Blenkers, T., Reich-Schupke, S., et al.: Occlusion rate, venous symptoms and patient satisfaction after radiofrequency-induced thermotherapy (RFITT®): are there differences between the great and the small saphenous veins? Vasa, 2015, 44(3), 203–210.

  • 30

    Merchant, R. F., Pichot, O., Closure Study Group: Long-term outcomes of endovenous radiofrequency obliteration of saphenous reflux as a treatment for superficial venous insufficiency. J. Vasc. Surg., 2005, 42(3), 502–509.

  • 31

    Spiliopoulos, S., Theodosiadou, V., Sotiriadi, A., et al.: Endovenous ablation of incompetent truncal veins and their perforators with a new radiofrequency system. Mid-term outcomes. Vascular, 2015, 23(6), 592–598.

  • 32

    Kalteis, M., Adelsgruber, P., Messie-Werndl, S., et al.: Five-year results of a randomized controlled trial comparing high ligation combined with endovenous laser ablation and stripping of the great saphenous vein. Dermatol. Surg., 2015, 41(5), 579–586.

  • 33

    Golbasi, I., Turkay, C., Erbasan, O., et al.: Endovenous laser with miniphlebectomy for treatment of varicose veins and effect of different levels of laser energy on recanalization. A single center experience. Lasers Med. Sci., 2015, 30(1), 103–108.

  • 34

    Flessenkämper, I., Hartmann, M., Hartmann, K., et al.: Endovenous laser ablation with and without high ligation compared to high ligation and stripping for treatment of great saphenous varicose veins: Results of a multicentre randomised controlled trial with up to 6 years follow-up. Phlebology, 2016, 31(1), 23–33.

  • 35

    El-Sheikha, J., Nandhra, S., Carradice, D., et al.: Clinical outcomes and quality of life 5 years after a randomized trial of concomitant or sequential phlebectomy following endovenous laser ablation for varicose veins. Br. J. Surg., 2014, 101(9), 1093–1097.

  • 36

    Scarpelli, P., Maggipinto, A., Leopardi, M., et al.: An update in varicose vein pathology after ten years of endovenous laser therapy (EVLT) with a 980 nm diode laser: clinical experience of a single center. Laser Ther., 2013, 22(4), 269–273.

  • 37

    Rasmussen, L., Lawaetz, M., Bjoern, L., et al.: Randomized clinical trial comparing endovenous laser ablation and stripping of the great saphenous vein with clinical and duplex outcome after 5 years. J. Vasc. Surg., 2013, 58(2), 421–426.

  • 38

    Witte, M. E., Reijnen, M. M., de Vries, J. P., et al.: Mechanochemical endovenous occlusion of varicose veins using the ClariVein® device. Surg. Technol. Int., 2015, 26, 219–225.

  • 39

    Woźniak, W., Mlosek, R. K., Ciostek, P.: Assessment of the efficacy and safety of steam vein sclerosis as compared to classic surgery in lower extremity varicose vein management. Wideochir. Inne Tech. Maloinwazyjne, 2015, 10(1), 15–24.

  • 40

    Van der Velden, S. K., Biemans, A. A., De Maeseneer, M. G., et al.: Five-year results of a randomized clinical trial of conventional surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy in patients with great saphenous varicose veins. Br. J. Surg., 2015, 102(10), 1184–1194.

  • 41

    Shadid, N., Ceulen, R., Nelemans, P., et al.: Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein. Br. J. Surg., 2012, 99(8), 1062–1070.

  • 42

    Chen, C. H., Chiu, C. S., Yang, C. H.: Ultrasound-guided foam sclerotherapy for treating incompetent great saphenous veins – results of 5 years of analysis and morphologic evolvement study. Dermatol. Surg., 2012, 38(6), 851–857.

  • 43

    Kalodiki, E., Lattimer, C. R., Azzam, M., et al.: Long-term results of a randomized controlled trial on ultrasound-guided foam sclerotherapy combined with saphenofemoral ligation vs. standard surgery for varicose veins. J. Vasc. Surg., 2012, 55(2), 451–457.

  • 44

    Disselhoff, B. C., der Kinderen, D. J., Kelder, J. C., et al.: Five-year results of a randomised clinical trial of endovenous laser ablation of the great saphenous vein with and without ligation of the saphenofemoral junction. Eur. J. Vasc. Endovasc. Surg., 2011, 41(5), 685–690.

  • 45

    Bradbury, A. W., Bate, G., Pang, K., et al.: Ultrasound-guided foam sclerotherapy is a safe and clinically effective treatment for superficial venous reflux. J. Vasc. Surg., 2010, 52(4), 939–945.

  • 46

    Chapman-Smith, P., Browne, A.: Prospective five-year study of ultrasound-guided foam sclerotherapy in the treatment of great saphenous vein reflux. Phlebology, 2009, 24(4), 183–188.

  • 47

    Hamel-Desnos, C., Ouvry, P., Benigni, J. P., et al.: Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. “The 3/1 Study”. Eur. J. Vasc. Endovasc. Surg., 2007, 34(6), 723–729.

  • 48

    Besset, J. F.: My experience with cryosurgery. Phlebologie, 1989, 42(4), 579–583.

  • 49

    Chandler, J. G., Pichot, O., Sessa, C., et al.: Defining the role of extended saphenofemoral junction ligation: a prospective comparative study. J. Vasc. Surg., 2000, 32(5), 941–953.

  • 50

    Dexter, D., Kabnick, L., Berland, T., et al.: Complications of endovenous lasers. Phlebology, 2012, 27(Suppl. 1), 40–45.